$JANX
Janux Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$18.50
▲+0.00%+$0.000
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateJanux Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is JANX up today? It is at $18.50 (+0.00%), and our scanner flagged it 43 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment JANX spikes, and full due diligence on JANX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $JANX 43 times in the last 30 days. Create a free account to track $JANX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on JANX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for JANX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Campbell David Alan Officer | Sold (automatic/other) | -124K 0.2% of company | sold 32% | 265K | n/a | Jul 31, 26 |
Campbell David Alan Officer | Other | 7K 0.01% of company | added 1.8% | 389K | $29K at $4.21 | Jul 8, 26 |
Barrett Ronald W Director | Acquired (grant/award) | +6K | added 88% | 12K | n/a | Jun 11, 26 |
Dobmeier Eric Director | Acquired (grant/award) | +6K | added 55% | 15K | n/a | Jun 11, 26 |
Capps Vickie L Director | Acquired (grant/award) | +6K | added 7.4% | 80K | n/a | Jun 11, 26 |
Kung Winston Director | Acquired (grant/award) | +6K | added 88% | 12K | n/a | Jun 11, 26 |
Hernday Natasha Director | Acquired (grant/award) | +6K | added 55% | 15K | n/a | Jun 11, 26 |
Simson Jake Director | Acquired (grant/award) | +6K | added 88% | 12K | n/a | Jun 11, 26 |
Ra Capital Management, L.P. Director | Acquired (grant/award) | +6K | added <0.1% | 11.20M | n/a | Jun 11, 26 |
Doyle Janeen Noel Officer | Sold (automatic/other) | -4K | sold 5.1% | 76K | $57K at $14.03 | Jun 2, 26 |
Dobek Maria Officer | Sold (automatic/other) | -2K | sold 5.9% | 32K | $29K at $14.17 | May 11, 26 |
Go William Officer | Acquired (grant/award) | +44K 0.07% of company | n/a | 44K | n/a | Feb 2, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on JANX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for JANX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
JANX last traded at $18.50, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Janux Therapeutics, Inc. Common Stock (JANX) is next expected to report earnings on Thursday, November 5, 2026, about 28 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The JANX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged JANX 43 times in the last 30 days.
JANX (Janux Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $1.13B in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge JANX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$JANX discussion
Sign in to ask a question or join the discussion.